Vaccines activating cancers
Dr. John CampbellPublished on June 7, 2026
Summary authored by editor@wellifi.com
TLDR Summary
Professor Angus Dalgleish raises concerns about potential links between COVID vaccines and an increase in cancer cases. His observations highlight the need for further investigation into how mRNA technology may impact immune response and cancer progression.
Key Points
- Professor Dalgleish observed cancer relapses in patients after receiving COVID vaccine boosters.
- The vaccines may disrupt T cell function, leading to reduced immune response against cancer.
- There has been a concerning increase in aggressive cancers at younger ages.
- mRNA from vaccines can potentially integrate into DNA and activate oncogenes.
- Current medical practices may overlook the vaccine history of cancer patients.
Understanding the Controversy: COVID Vaccines and Cancer Links
In a recent talk, Professor Angus Dalgleish shared insights regarding the potential links between COVID vaccines and cancer, as well as the suppression of vital medical information. With nearly 50 years of experience in medicine, particularly in immunotherapy and oncology, Professor Dalgleish's testimony has raised alarming questions about the implications of mRNA vaccines on cancer patients.
Professor Dalgleish's Observations
In early 2022, while treating melanoma patients—known for being aggressive and often fatal—Professor Dalgleish observed an unsettling trend. Despite successfully keeping his patients alive for between 3 to 18 years, he noted a sudden relapse in six patients within just six weeks of receiving COVID vaccine booster doses. This led him to explore the underlying reasons for their relapses.
Investigating T Cell Response
As an oncologist, Professor Dalgleish understood that T lymphocytes play a crucial role in controlling melanoma. His research indicated that the COVID vaccines might be disturbing the T cell physiology, leading to T cell suppression. This suppression could result in the immune system not attacking the cancer cells as it should, allowing them to proliferate unchecked.
Shifts in Immunoglobulin Production
Professor Dalgleish also noted a concerning switch in the type of immunoglobulins produced by lymphocytes. Instead of generating antibodies that fight infections and cancer, there was a shift toward immunoglobulins that tolerate these threats. This change could explain why cancer cells, once in remission, began to grow again.
Emerging Cancer Trends
The ramifications of these findings extend beyond melanoma. Reports have emerged of other cancers, such as colorectal, breast, and prostate cancer, presenting more aggressively and at younger ages. This phenomenon suggests that the impact of mRNA vaccines on the immune system may be broader and more dangerous than initially understood.
Mechanisms of mRNA and Cancer
Professor Dalgleish highlighted that research has identified at least 12 mechanisms through which mRNA can integrate into cellular DNA, potentially leading to oncogene activation. This raises critical concerns about how the vaccines could inadvertently promote cancer development.
The Need for Further Investigation
Despite the lack of widespread acknowledgment of these potential links within the medical community, Professor Dalgleish argues that it is essential to take vaccine histories seriously when diagnosing cancer. He believes that the current use of mRNA technology in vaccines should be halted until more is understood about its implications for cancer and overall health.
Conclusion
The testimony of Professor Angus Dalgleish serves as a call to action for the medical community to investigate the potential connections between COVID vaccines and cancer more thoroughly. As vaccination continues, understanding the implications of these vaccines remains crucial, not only for patient safety but also for advancing cancer treatment strategies.
For those interested, a more detailed account of the hearings can be accessed through the Homeland Security Government Affairs website.